The Cigna Group (CI) Q2 2025 earnings summary

Executive summary

• Q2 2025 revenues rose 11% year-over-year to $67.2 billion, driven by Evernorth Health Services and specialty pharmacy growth.

• Adjusted EPS for Q2 2025 was $7.20, with net income flat year-over-year at $1.5–$1.63 billion; six-month net income rose 115% to $3.04 billion, reflecting the absence of prior-year equity security impairments.

• Reaffirmed full-year 2025 adjusted EPS outlook of at least $29.60, reflecting confidence in the diversified business model and disciplined execution.

• The sale of Medicare Advantage and related businesses to HCSC closed in March 2025, generating $4.2 billion in cash proceeds and a $37 million pre-tax gain.

• Strategic optimization program launched, incurring $344 million in pre-tax costs year-to-date.

Financial highlights

• Q2 2025 revenue reached $67.2 billion; adjusted EPS was $7.20; adjusted income from operations was $1.9 billion ($7.20 per share), up from $6.72 per share.

• Evernorth segment contributed over 60% of enterprise earnings, with Q2 revenues of $57.8 billion and pre-tax adjusted earnings of $1.7 billion.

• Specialty and care services revenue grew 13% to $25.9 billion; normalized pre-tax adjusted earnings up 12% year-over-year.

• Cigna Healthcare Q2 revenues were $10.8 billion; pre-tax adjusted earnings $1.1 billion; medical care ratio 83.2%.

• Net after-tax special item charges of $171 million, or $0.64 per share, recorded in Q2.

Outlook and guidance

• Reaffirmed full-year 2025 adjusted EPS guidance of at least $29.60.

• Evernorth full-year 2025 pre-tax adjusted earnings expected to be at least $7.2 billion; Cigna Healthcare at least $4.125 billion, with a medical care ratio of 83.2%-84.2%.

• Third quarter adjusted EPS expected to be slightly above 25% of full-year outlook.

• Guidance includes anticipated share repurchases and dividends; excludes effects of future business combinations.

• Management cautions against extrapolating full-year results from interim periods due to seasonality and market conditions.